Cited by 260Long-Term Effects of COVID-19SARS-CoV-2 and COVID-19 ResearchInfectious Encephalopathies and Encephalitis

Does SARS‐Cov‐2 invade the brain? Translational lessons from animal models

Open access
Natoli, S., Oliveira, V., Calabresi, P., Maia, L. F., Pisani, A.·2020·European Journal of Neurology

Abstract

The current coronavirus disease (COVID‐19) outbreak, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has raised the possibility of potential neurotropic properties of this virus. Indeed, neurological sequelae of SARS‐CoV‐2 infection have already been reported and highlight the relevance of considering the neurological impact of coronavirus (CoV) from a translational perspective. Animal models of SARS and Middle East respiratory syndrome, caused by structurally similar CoVs during the 2002 and 2012 epidemics, have provided valuable data on nervous system involvement by CoVs and the potential for central nervous system spread of SARS‐CoV‐2. One key finding that may unify these pathogens is that all require angiotensin‐converting enzyme 2 as a cell entry receptor. The CoV spike glycoprotein, by which SARS‐CoV‐2 binds to cell membranes, binds angiotensin‐converting enzyme 2 with a higher affinity compared with SARS‐CoV. The expression of this receptor in neurons and endothelial cells hints that SARS‐CoV‐2 may have higher neuroinvasive potential compared with previous CoVs. However, it remains to be determined how such invasiveness might contribute to respiratory failure or cause direct neurological damage. Both direct and indirect mechanisms may be of relevance. Clinical heterogeneity potentially driven by differential host immune‐mediated responses will require extensive investigation. Development of disease models to anticipate emerging neurological complications and to explore mechanisms of direct or immune‐mediated pathogenicity in the short and medium term is therefore of great importance. In this brief review, we describe the current knowledge from models of previous CoV infections and discuss their potential relevance to COVID‐19.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/ene.14277

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Evidence is accumulating suggesting that SARS-CoV-2 initially infects peripheral nerve terminals and, through a trans-synaptic mechanism, enters the CNS.

    “In addition to the passage through the nasal neuro-epithelium route, independently from lower airway passage, evidence is accumulating suggesting that the virus initially infects peripheral nerve terminals and, through a trans-synaptic mechanism, enters the CNS [174].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Li W, Moore MJ, Vasilieva N, et al. Angiotensin-con- verting enzyme 2: a functional receptor for SARS coron- avirus. Nature 2003; 426: 450-454.
  2. Kim JE, Heo JH, Kim HO, et al. Neurological compli- cations during treatment of middle east respiratory syn- drome. J Clin Neurol 2017; 13: 227-233.

Cited by

Sorted by citations

Authors
Natoli, S., Oliveira, V., Calabresi, P., Maia, L. F., & Pisani, A.
Affiliations
  • University of Rome Tor Vergata (IT)
  • Centro Hospitalar do Porto (PT)
  • Agostino Gemelli University Polyclinic (IT)
  • Department of Neurology Centro Hospitalar Universitário do Porto Porto Portugal
Corresponding author
Pisani, A.
Venue
European Journal of Neurology
Publisher
Wiley
Published
2020-05-22
Volume
27
Issue
9
Pages
1764-1773
ISSN
  • 1351-5101 (ISSN-L)
  • 1468-1331
OpenAlex
W3020676731
Cited by
260
References
56
Citations by year
2026: 7 · 2025: 5 · 2024: 11 · 2023: 21 · 2022: 49 · 2021: 79 · 2020: 87
FWCI
6.63
Type
journal article
Language
en
Open access
Locations
  • European Journal of Neurology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion, other-oa)
  • Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
Keywords
SARS-CoV-2, COVID-19 pandemic, neurotropism, central nervous system infiltration, angiotensin-converting enzyme 2, spike protein, SARS-CoV, MERS-CoV, animal models, neurological complications, respiratory failure, host immune response
MeSH terms
COVID-19, SARS-CoV-2, Animals, Brain, Humans, Models, Animal, Endothelial Cells, Translational Research, Biomedical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review